PPB - Services

Complaints, Feedback and Enquiry

𝐏𝐏𝐁 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐬 𝐓𝐨𝐰𝐚𝐫𝐝𝐬 𝐈𝐌𝐃𝐑𝐅 𝐌𝐞𝐦𝐛𝐞𝐫𝐬𝐡𝐢𝐩: 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 – 14th March 2024

Washington DC – On March 14th, 2024, PPB took a significant step towards global collaboration and regulatory excellence. Under the leadership of CEO, Dr. F.M. Siyoi, the team convened in Washington DC to submit an application to join the International Medical Device Regulators Forum (IMDRF) as an affiliate member. During the Management Committee Closed Session, […]

𝐏𝐏𝐁 𝐀𝐭𝐭𝐚𝐢𝐧𝐬 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐚𝐬 𝐌𝐃𝐒𝐀𝐏 𝐀𝐟𝐟𝐢𝐥𝐢𝐚𝐭𝐞 𝐌𝐞𝐦𝐛𝐞𝐫, 𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝𝐬 𝐢𝐧 𝐊𝐞𝐧𝐲𝐚 – 13th March 2024

Washington DC – The Pharmacy and Poisons Board (PPB) has achieved a significant milestone by attaining official recognition as an MDSAP Affiliate Member for the Medical Devices Single Audit Program (MDSAP). This acknowledgment was made during the ongoing 25th session of the International Medical Devices Regulators Forum (IMDRF) in Washington DC from March 11th to […]

𝐄𝐧𝐡𝐚𝐧𝐜𝐢𝐧𝐠 𝐎𝐯𝐞𝐫𝐬𝐢𝐠𝐡𝐭 𝐨𝐟 𝐋𝐨𝐜𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬: 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐚𝐧𝐝 𝐏𝐨𝐢𝐬𝐨𝐧𝐬 𝐁𝐨𝐚𝐫𝐝 𝐈𝐧𝐢𝐭𝐢𝐚𝐭𝐞𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐌𝐞𝐞𝐭𝐢𝐧𝐠 – 27th February 2024

Nairobi, Kenya – Today, the Pharmacy and Poisons Board (PPB) convened a meeting with top management from local pharmaceutical manufacturing companies to discuss strategies for enhancing oversight of local manufacturers. The meeting highlighted the importance of implementing a rapid alert system to manage substandard and falsified medicines, as well as the application of a mandatory […]

𝟏𝟐𝟗 𝐀𝐩𝐩𝐫𝐞𝐡𝐞𝐧𝐝𝐞𝐝 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐁𝐨𝐚𝐫𝐝’𝐬 𝐂𝐫𝐚𝐜𝐤𝐝𝐨𝐰𝐧 𝐨𝐧 𝐈𝐥𝐥𝐞𝐠𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 – 19th February 2024

Nairobi, Kenya – Ensuring the safety and integrity of pharmaceuticals is paramount to safeguarding public health. The Pharmacy and Poisons Board crackdown on illegal pharmaceutical activities this week resulted in the apprehension of 129 individuals and seizure of over 200 cartons of illicit medicines across Nairobi, South Rift, and Western regions. The operation aimed to […]

Workshop Enhances Clinical Trials Oversight in Kenya – 9th February 2024

Machakos, Kenya – To enhance clinical trials oversight in Kenya, the Clinical Trials Division of the Pharmacy and Poisons Board, with support from the USAID/MTaPS program, hosted a workshop from 5th – 9th February 2024. The goal was to develop and review regulatory instruments, particularly focusing on crafting Good Clinical Practice (GCP) inspection guidelines and […]

Strengthening Risk Communication for Patient Safety – 9th February 2024

  Machakos, Kenya – In a bid to bolster patient safety and transparency in healthcare, the Pharmacy & Poisons Board (PPB) spearheaded a pivotal workshop in Machakos County from February 5th to 9th, 2024. The workshop, organized by the Department of Product Safety in collaboration with the Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, focused […]

PPB Workshop Advances Health Standards for Kenyan Product Manufacturers – 22nd January 2024

   Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) is hosting a three-day workshop for local Health Products and Technologies (HPTs) manufacturers. The workshop aims to share insights from the World Health Organization Global Benchmarking Tool Audit of PPB, addressing its implications for Kenyan pharmaceutical manufacturers, common deficiencies in baseline inspections, and providing guidance […]

𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐲 𝐚𝐧𝐝 𝐏𝐨𝐢𝐬𝐨𝐧𝐬 𝐁𝐨𝐚𝐫𝐝 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐬 𝐅𝐢𝐠𝐡𝐭 𝐀𝐠𝐚𝐢𝐧𝐬𝐭 𝐂𝐨𝐮𝐧𝐭𝐞𝐫𝐟𝐞𝐢𝐭 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐰𝐢𝐭𝐡 𝐊𝐞𝐲 𝐌𝐎𝐔, 16th January 2024

Nairobi, Kenya – Tuesday, January 16, marks a significant step forward in safeguarding the integrity of health products and technologies within Kenya. The Pharmacy and Poisons Board has formalized a crucial partnership by signing a Memorandum of Understanding with the Anti-Counterfeit Authority. This collaborative effort is designed to fortify the regulation and enforcement of the […]

𝐊𝐞𝐧𝐲𝐚 𝐂𝐨𝐦𝐦𝐞𝐦𝐨𝐫𝐚𝐭𝐞𝐬 𝐭𝐡𝐞 𝐑𝐚𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐀𝐟𝐫𝐢𝐜𝐚𝐧 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐀𝐠𝐞𝐧𝐜𝐲 (𝐀𝐌𝐀) 𝐓𝐫𝐞𝐚𝐭𝐲 – 24th November 2023

Nairobi, KENYA – Kenya commemorated a significant milestone with the ratification of the African Medicines Agency (AMA) treaty. The treaty aims to ensure the availability of safe health products across Africa and boost local manufacturing capacities. The PPB CEO, Dr. F. M. Siyoi, represented by Dr. Wilfred Ochieng, Director Pharmacy Practice highlighted the importance of […]

PPB Hosts Delegation from Wuhan Institute – 17th November 2023

Nairobi, Kenya – The Pharmacy and Poisons Board (PPB) hosted a delegation from the Wuhan Institute of Biological Products in China, visiting the PPB laboratory on Friday. The meeting aimed to explore collaboration opportunities between PPB and the institute, focusing on enhancing capacity building and fortifying the country’s testing capabilities for vaccines and other biologicals.